Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Eotaxin potentiates antigen-dependent basophil IL-4 production.

G Devouassoux1, D D Metcalfe, C Prussin

  • 1Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|August 24, 1999
PubMed
Summary

Eotaxin, a chemokine, amplifies allergic inflammation by boosting interleukin-4 (IL-4) production in basophils. This study reveals a novel non-chemotactic role for eotaxin in potentiating allergic responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eczema following IL-5 inhibitors for the treatment of severe asthma with improvement after switching to an IL-4Rα mAb.

The journal of allergy and clinical immunology. In practice·2025
Same author

[Emergency room visits for asthma and the reported outcomes: The PASS survey by the CRISALIS network].

Revue des maladies respiratoires·2025
Same author

Management of asthma during the Coronavirus disease 2019 outbreak.

Respiratory medicine and research·2020
Same author

Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients.

Orphanet journal of rare diseases·2020
Same author

[Management of mild asthma in 2019-2020: What about new international therapeutic proposals (GINA 2019)?]

Revue des maladies respiratoires·2020
Same author

Clinical ACO phenotypes: Description of a heterogeneous entity.

Respiratory medicine case reports·2019

Area of Science:

  • Immunology
  • Allergy Research
  • Cellular Signaling

Background:

  • Basophils are key producers of interleukin-4 (IL-4), a critical mediator of allergic inflammation.
  • Eotaxin is known to induce chemotaxis via the CC chemokine receptor 3 (CCR3) on basophils, eosinophils, and Th2 cells.

Purpose of the Study:

  • To investigate potential non-chemotactic proinflammatory activities of eotaxin on basophils.
  • To determine the effect of eotaxin on basophil IL-4 expression and production.

Main Methods:

  • Flow cytometry was used to assess IL-4 expression in basophils.
  • Enzyme-linked immunosorbent assay (ELISA) quantified IL-4 release from purified basophils.
  • Dose-response curves and antibody blockade of CCR3 were employed to analyze eotaxin's effects.

Related Experiment Videos

Main Results:

  • Eotaxin alone did not induce IL-4 production but significantly enhanced allergen-stimulated IL-4 expression.
  • Eotaxin increased IL-4 release from purified basophils 2- to 4-fold and shifted the dose-response curve to antigen (Ag) by 40-fold.
  • The effect of eotaxin was observed at physiological concentrations, blocked by anti-CCR3 antibodies, and mimicked by other CCR3 ligands. Eotaxin synergistically augmented IL-3-primed IL-4 production.

Conclusions:

  • Eotaxin and other CCR3 chemokine ligands possess a novel function in potentiating antigen-mediated IL-4 production by basophils.
  • These findings suggest a significant non-chemotactic role for CC chemokines in the pathogenesis and amplification of allergic inflammation.